Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls

Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls

PurposeTo investigate the effectiveness and safety of gonadotropin-releasing hormone analogue (GnRHa) in combination with recombinant human growth hormone (rhGH) in girls with central precocious puberty (CPP).MethodsClinical data of 80 girls diagnosed with idiopathic central precocious puberty (ICPP...

Full description

Bibliographic Details
Main Authors:	Yuzhen Shi, Ziyi Ma, Xi Yang, Yanqin Ying, Xiaoping Luo, Ling Hou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Endocrinology
Subjects:	central precocious puberty gonadotropin-releasing hormone analogue recombinant human growth hormone height growth velocity predicted adult height
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.1085385/full

Similar Items

Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty
by: Eun Hye Yang, et al.
Published: (2023-03-01)

The Effect of Gonadotropin-releasing Hormone Analog Treatment on Body Mass Index and Height in Female Patients with Central Precocious Puberty
by: Muammer Büyükinan, et al.
Published: (2019-03-01)

Age of menarche and near adult height after long-term gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty
by: Joon-Woo Baek, et al.
Published: (2014-03-01)

Comparison of the effect of gonadotropin-releasing hormone agonist dosage in girls with central precocious puberty
by: Shinyoung Jang, et al.
Published: (2023-02-01)

The impact of BMI on long-term anthropometric and metabolic outcomes in girls with idiopathic central precocious puberty treated with GnRHas
by: Patrizia Bruzzi, et al.
Published: (2022-10-01)

Treatment with Depot Leuprolide Acetate in Girls with Idiopathic Precocious Puberty: What Parameter should be Used in Deciding on the Initial Dose?
by: Doğuş Vurallı, et al.
Published: (2020-03-01)

Final adult height in children with central precocious puberty – a retrospective study
by: Taja Knific, et al.
Published: (2022-12-01)

Elevated Pre-injection Basal Luteinizing Hormone Concentrations are Common in Girls Treated for Central Precocious Puberty
by: Stefanie Schubert, et al.
Published: (2021-06-01)

Clinical data and basal gonadotropins in the diagnosis of central precocious puberty in girls
by: Teodoro Durá-Travé, et al.
Published: (2021-03-01)

Clinical and Laboratory Parameters of Gonadotropin-Releasing Hormone Analog Treatment Effectiveness in Children with Precocious Puberty
by: Lívia Grimaldi Abud Fujita, et al.
Published: (2019-11-01)

Adult height in girls with central precocious puberty without gonadotropin-releasing hormone agonist treatment: a retrospective case-control study
by: Hyun Ji Jang, et al.
Published: (2023-11-01)

Diagnostic value of urinary luteinizing hormone levels in the monitoring of precocious puberty treatment
by: Özge Yüce, et al.
Published: (2020-03-01)

Can Body Mass Index Affect Height Growth at Menarche among Girls Receiving Treatment for Early Puberty? A Retrospective Study in Korean Girls
by: Sun-Jin Lee, et al.
Published: (2022-01-01)

Elevated Random Luteinizing Hormone is an Unreliable Indicator for Pubertal Suppression in Girls Treated with Monthly Leuprolide for Idiopathic Central Precocious Puberty
by: Pattara Wiromrat, et al.
Published: (2019-09-01)

Impact of 6-month triptorelin formulation on predicted adult height and basal gonadotropin levels in patients with central precocious puberty
by: Eunjoo Yoo, et al.
Published: (2023-02-01)

Efficacy and safety of a 4-year combination therapy of growth hormone and gonadotropin-releasing hormone analogue in pubertal girls with short predicted adult height
by: Hilde Dotremont, et al.
Published: (2023-03-01)

Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States
by: Jadranka Popovic, et al.
Published: (2022-10-01)

The utilization of basal luteinizing hormone in combination with the basal luteinizing hormone and follicle-stimulating hormone ratio as a diagnostic tool for central precocious puberty in girls
by: Nuntika Chotipakornkul, et al.
Published: (2023-06-01)

Precocious puberty and microbiota: The role of the sex hormone–gut microbiome axis
by: Valeria Calcaterra, et al.
Published: (2022-10-01)

The effect of gonadoliberin analog treatment in precocious puberty on polycystic ovarian syndrome prevalence in adulthood
by: Dominika Orszulak, et al.
Published: (2024-01-01)

The effects of gonadotropin-releasing hormone agonist on final adult height among girls with early and fast puberty
by: Chin-Hui Tseng, et al.
Published: (2023-11-01)

The value of luteinizing hormone basal values and sex hormone-binding globulin for early diagnosis of rapidly progressive central precocious puberty
by: Meiyu Zhang, et al.
Published: (2024-01-01)

Slower progression of central puberty in overweight girls presenting with precocious breast development
by: Mi Ra Kim, et al.
Published: (2022-09-01)

Gonadotropin dependent premature pubertal development in girls. Description of clinical cases
by: A. V. Vitebskaya, et al.
Published: (2017-03-01)

The Assessment of Brain Volume Differences in Idiopathic Central Precocious Puberty Girls; Comparison of Age-Matched Girls and Normal Puberty Girls
by: Shin-Eui Park, et al.
Published: (2021-09-01)

Long-Term Results in Girls with Central Precocious Puberty After Leuprolide Acetate Treatment
by: Esra BEŞER ÖZMEN, et al.
Published: (2020-12-01)

Does Basal Morning Luteinizing Hormone (bLH) Predict Central Precocious Puberty (CPP) in Girls?
by: Federico Baronio, et al.
Published: (2024-03-01)

A Testicular Leydig Cell Tumor; An Uncommon Cause of Precocious Puberty: A Case Report With Secondary Central Precocious Puberty
by: Seyede Tahereh Mousavi, et al.
Published: (2023-04-01)

Advanced bone age as an indicator facilitates the diagnosis of precocious puberty
by: Yue‐Qin Xu, et al.
Published: (2018-01-01)

A 4-Year-Old Girl with Precocious Puberty
by: Poly Begum, et al.
Published: (2016-09-01)

Normalization of puberty and adult height in girls with Turner syndrome: results of the Swedish Growth Hormone trials initiating transition into adulthood
by: Berit Kriström, et al.
Published: (2023-07-01)

Comparative efficacy of aromatase inhibitors and gonadotropin-releasing hormone analogue in increasing final height of idiopathic short stature boys: a network meta-analysis
by: Siqi Wang, et al.
Published: (2023-04-01)

Machine Learning Approach for Prediction of the Test Results of Gonadotropin-Releasing Hormone Stimulation: Model Building and Implementation
by: Yu-Shao Chen, et al.
Published: (2023-04-01)

Evaluation of Electrocardiographic Changes in Girls Receiving Gonadotropin-Releasing Hormone Analogs for Precocious Puberty
by: Eren Er, et al.
Published: (2023-09-01)

Differential diagnosis of precocious puberty in girls during the COVID-19 pandemic: a pilot study
by: Huihui Sun, et al.
Published: (2023-04-01)

Myopic Progression in Girls with Gonadotrophin-Releasing Hormone Agonist Treatment for Central Precocious Puberty
by: Seung Ah Chung, et al.
Published: (2021-02-01)

Normal Adult Height in an Untreated Boy With McCune-Albright Syndrome Presenting With Precocious Puberty
by: Ugen Lhamu, MD, et al.
Published: (2023-05-01)

Precocious puberty or growth hormone deficiency as initial presentation in Mayer-Rokitansky-kuster-Hauser syndrome: a clinical report of 5 cases
by: Zhuanzhuan Ai, et al.
Published: (2022-07-01)

Electrocardiogram Changes Following the Treatment with Gonadotropin-Releasing Hormone Agonists in Patients with Precocious Puberty
by: Ali Bagherzadeh, et al.
Published: (2021-11-01)

The Growth Hormone Deficiency (GHD) Reversal Trial: effect on final height of discontinuation versus continuation of growth hormone treatment in pubertal children with isolated GHD—a non-inferiority Randomised Controlled Trial (RCT)
by: Elizabeth Brettell, et al.
Published: (2023-08-01)